The 10th annual RTRX experience, slated for August 4-8 in Columbus, OH, in partnership with Pelotonia’s Ride Weekend, is growing to include a broader audience of leaders from across the nation, and increase cancer research funding led by Pelotonia. With a new location at Express Live! and internationally-acclaimed speakers, the experience is expected to draw innovators and leaders nationwide.
Programming includes Dr. Robert Livingston, Lecturer of Public Policy of Harvard University and one of the nation’s leading experts on the science underlying bias and racism. He recently authored the timely and impactful book The Conversation: How Seeking and Speaking the Truth About Racism Can Radically Transform Individuals and Organizations. Alex Sheen, Founder, Because I said I would, a social movement dedicated to the betterment of humanity through promises made and kept. As one of the world’s foremost experts on accountability and commitment, Sheen is a five-time TEDxTalk speaker, author, podcast host and humanitarian.
Jeremy Hunter, PhD, Founding Director, Executive Mind Leadership Institute, Claremont Drucker School of Management. He develops foundational works on mindfulness and leadership and has designed and led leadership development programs spanning large corporations to nonprofits. A Leadership in the Arena Panel featuring three CEOs from across industries and sectors to address leading through a tumultuous time of global pandemic, racial disparities and economic crisis. Pelotonia CEO Doug Ulman and Heather Hampel, Genetic Research at The Ohio State University Comprehensive Cancer Center, presenting exciting updates on the life-saving research funded by RTRX.
RTRX was founded by Rockbridge in 2012 to convene business leaders and benefit innovative cancer research funded by Pelotonia. The movement is designed to empower attendees across all aspects of life through dynamic programming, business development, leisure activities and a direct link to social change and philanthropy. The experience takes place each year in partnership with Pelotonia’s Ride Weekend, and all event revenue is invested in innovative cancer research, with $5 million raised to date for research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) through Pelotonia. RTRX has a unique approach by creating an experience that is relevant to all aspects of life—personally and professionally—for both the organization and the individual.
“From the start, RTRX was designed to make people better. Better in our businesses, our families, and our communities, and as a result, better for the world.” said Jim Merkel, founder/CEO of Rockbridge. “We’re humbled by the incredible impact made in ten short years, and are incredibly excited for the possibilities ahead.”
Registration includes welcome party, expansive programming, networking and happy hour, and a direct impact with Pelotonia to join the mission to end cancer.
About RTRX: RTRX is a movement that empowers and mobilizes individuals and businesses to do good by moving from thought leadership to change leadership. The annual four-day experience in partnership with Pelotonia’s Ride Weekend brings hundreds of leaders across industries, bold entrepreneurs, mavericks, and other forward-thinkers together at the intersection of leadership and innovation. Attendees connect, learn and collaborate to build tools they need to take on the challenges of our times, unlock new business opportunities and participate in shaping the future, all while benefiting innovative cancer research. For more information, visit RTRX online https://www.rtrx.co, or via Instagram @rtrx_hq.
Wednesday, August 4
RTRX WELCOME PARTY
A business development networking event
A&R Music Bar
Thursday, August 5
THE RTRX EXPERIENCE
9:30 am – 4:30 pm
Friday, August 6
Pelotonia Opening Ceremony
6:00 – 8:30 pm
Lower.com Field, the NEW home to the Columbus Crew
Saturday & Sunday, August 7 & 8
PELOTONIA’S SIGNATURE RIDE EXPERIENCE
A powerful and emotional ride experience to accelerate innovative cancer research.